Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Week In Review: October Is Finally Over
Nov 02, 2008 12:12 PM
- China Sky One Wins SFDA Approval for Two More Products
Oct 30, 2008 03:19 PM
- China Sky One Buys Breast Lesion Drug
Oct 29, 2008 04:45 PM
- The Week in Review: Broad Themes And Deals
Oct 25, 2008 04:56 PM
- China Sky One Inks Distribution Deal for Asthma Patch
Oct 23, 2008 02:14 PM
- The Week In Review: The FDA, China Deals And Earnings
Oct 18, 2008 08:47 PM
- China Sky One Starts Production at New Subsidiary
Oct 14, 2008 05:10 PM
- The Week In Review: Deals, Development And Financials
Sep 28, 2008 01:59 PM
- China Sky One Raises 2008 Guidance
Sep 26, 2008 02:15 PM
- The Week in Review: A Big Question
Sep 21, 2008 04:50 PM
- China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
Nov 13, 2008 08:00 AM
- China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
Nov 10, 2008 06:01 AM
- /C O R R E C T I O N -- China Sky One Medical, Inc./
Nov 04, 2008 06:31 PM
- China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
Nov 04, 2008 05:09 PM
- NASDAQ OMX Announces Third Quarter 2008 New Listings Statistics
Oct 27, 2008 03:03 AM
- China Sky One Medical, Inc., to Present at Rodman & Renshaw Conference
Oct 20, 2008 08:03 AM
- China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
Oct 14, 2008 08:04 AM
- China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
Sep 25, 2008 04:32 PM
- China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification
Sep 19, 2008 08:01 AM
- China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
Aug 08, 2008 08:14 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
CSKI
|
Compare to S&P
|
| YTD |
-0.01 %
|
-0.01 %
|
| 4 Weeks |
13.70 %
|
22.90 %
|
| 12 Weeks |
-20.05 %
|
10.83 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 20.00 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: 25.05 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
